Buscador de ensayos clínicos de Fight CRC

Fecha en que se añadió el juicio
View:
NCT ID Title Fase Date Added Ubicación Prior IO Allowed CRC-directed Status Drogas Etiquetas
NCT ID
NCT03096093
TitleInvestigation of a Therapeutic Vaccine (ACIT-1) in Cancer Fase
Phase 1, Phase 2
Date Added
2017-03-30
Ubicación
Reino Unido
Prior IO Allowed
CRC-directed
No
Status
Activo, no recluta
Drogas
ACIT-1
Etiquetas
MSS/ MMRp
NCT ID
NCT04130854
TitleINNATE: Immunotherapy During Neoadjuvant Therapy for Rectal Cancer Fase
Fase 2
Date Added
2019-10-18
Ubicación
Arizona, United States
North Carolina, United States
Oregon, United States
Texas, United States
Prior IO Allowed
No
CRC-directed
Status
Activo, no recluta
Drogas
APX005M, mFOLFOX, and Radiation Therapy 5Gy x 5 days, mFOLFOX and Radiation Therapy 5Gy x 5 days
Etiquetas
MSS/ MMRp
NCT ID
NCT05611034
TitleIn Vivo Lung Perfusion (IVLP) for Colorectal Cancer Metastatic to Lung Fase
Fase 1
Date Added
2022-11-09
Ubicación
Canadá
Prior IO Allowed
CRC-directed
Status
Reclutamiento
Drogas
oxaliplatin
Etiquetas
MSI-H/ MMRd, MSS/ MMRp
NCT ID
NCT05299840
TitleImpact of Using the Oncogramme(R) Device to Select the First Line of Treatment for Patients With Metastatic Colorectal Cancer Fase
No aplicable
Date Added
2022-03-29
Ubicación
Francia
Prior IO Allowed
No
CRC-directed
Status
Reclutamiento
Drogas
Etiquetas
MSI-H/ MMRd, MSS/ MMRp
NCT ID
NCT01174121
TitleImmunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Cancer Fase
Fase 2
Date Added
2010-08-03
Ubicación
Maryland, United States
Prior IO Allowed
CRC-directed
Status
Reclutamiento
Drogas
Aldesleukin, Cyclophosphamide, Fludarabine, Pembrolizumab (Keytruda), Young TIL
Etiquetas
MSI-H/ MMRd, MSS/ MMRp
NCT ID
NCT04444622
TitleImmunotherapy for Third Line Metastatic Colorectal Cancer Fase
Fase 2
Date Added
2020-06-23
Ubicación
Florida, United States
Michigan, United States
New Jersey, United States
New York, United States
Prior IO Allowed
No
CRC-directed
Status
Activo, no recluta
Drogas
Etiquetas
MSS/ MMRp
NCT ID
NCT03658785
TitleInmunoterapia para el tratamiento de tumores sólidos avanzados Fase
Fase 1
Date Added
2018-09-05
Ubicación
China
Prior IO Allowed
CRC-directed
No
Status
Reclutamiento
Drogas
Aldesleukin, Cyclophosphamide, Fludarabine, TIL
Etiquetas
MSI-H/ MMRd, MSS/ MMRp
NCT ID
NCT06515314
TitleHRYZ-T102 TCR-T Cell for AFP Positive Advanced HCC and Other Solid Tumors Fase
Fase 1
Date Added
2024-07-23
Ubicación
China
Prior IO Allowed
CRC-directed
No
Status
Reclutamiento
Drogas
Etiquetas
MSI-H/ MMRd, MSS/ MMRp
NCT ID
NCT03366155
TitleHepatic Artery Infusion Pump Chemotherapy With Floxuridine and Dexamethasone in Combination With Systemic Chemotherapy for Patients With Colorectal Cancer Metastatic to the Liver Fase
Fase 2
Date Added
2017-12-08
Ubicación
Maryland, United States
Prior IO Allowed
No
CRC-directed
Status
Activo, no recluta
Drogas
5FU, cetuximab, FUDR-Dex, Irinotecan, Medtronic SynchroMed II Pump with Codman 3000 Constant Flow Pump Catheter, OneRNA, oxaliplatin, panitumumab
Etiquetas
MSI-H/ MMRd, MSS/ MMRp
NCT ID
NCT06558773
TitleGSL Synthetase Inhibitor Plus Immune Checkpoint Inhibitor and/or Regorafenib in Previously Treated pMMR/MSS CRC. Fase
Fase 2
Date Added
2024-08-19
Ubicación
China
Prior IO Allowed
CRC-directed
Status
Aún no se ha contratado
Drogas
Etiquetas
MSS/ MMRp